A question lands. Why does this trial respond at 70% in one cancer type and 2% in another with the same drug? Why does this organisation keep starting change initiatives that go quiet six months in? Why does a cell decide to divide today and not yesterday?
The cases we like best are the ones nobody has been able to read cleanly yet, where the standard framing has already been tried and the answer it gave was not quite right.
A small practice can look at cells one week and at organisations the next because we are not the specialists in either. We are looking for the same shape in each. A cycle running, a cycle stalling, a cycle losing its closure. The shape has the same architecture in a cell as in a company, because dissipation has one structure.
What changes between substrates is the vocabulary and the instruments. A T cell stalled before its first division and a research program stalled before its first publication are different things in different materials. The substrate expert — the biologist or the clinician or the founder — knows the material. We try to read the shape, and the reading lands back with them.
Most of what we produce is a structural read. Where the cycle is stalling. What that tells you about which intervention might land. Which interventions act at that position and which act somewhere else.
The intervention itself usually already exists. Often it is being applied to the wrong cases. Sometimes what changes the outcome is a re-segmentation, a different measurement, a sharper question, rather than a new drug or a new program.
We use whatever instrument matches the resolution the question requires. Single-cell sequencing when it is available. Bulk RNA when it is not. Cell fractions when the budget is smaller. Published cohorts when the cohort we need has already been collected. Structured conversations when the system is an organisation rather than a tissue.
Our published work lives in immuno-oncology because biology has the sharpest instruments. If the framework is right, it should be measurable there. If it is right there, the same shape should hold where the instruments are blunter. That is what we are testing.
We take on a handful of engagements at a time. Most start with a conversation, no commitment, where we look at what you have and talk about whether the framework might be useful. The conversation is free either way.
Get in touch.